Synthesis and characterization of covalent ligand library
Division Of Basic Sciences - Nci
Investigators
Linked publications, trials & patents
Abstract
Main activities of this project include the exploration of chemical functionalities to increase the number of electrophilic warhead options for the design of covalent modulators. Our initial efforts are focused on exploring unique and unstudied electrophilic moieties derived from structures of known natural products. 3-halo-4,5-dihydroisoxazole that is found in natural product acivicin reacts with cysteine residues activated by surrounding amino acid residues in the active site of a number of enzymes. To systematically evaluate 3-bromo-4,5-dihydroisoxazole as a molecular warhead, we have devised a synthetic strategy to rapidly install the electrophilic warhead into a library of fragments and have synthesized the first set of 300 compounds. For characterization of electrophilic compounds, we measure intrinsic chemical reactivity and their tunability for specific protein modification. We are currently employing reactivity-driven chemoproteomic methods to map the target sites of proteins. Combining competitive gel analysis and quantitative mass spectrometry-based profiling, we identify specific target engagement of a given covalent compound in T cell signaling. Our study demonstrates that 3-bromo-4,5-dihydroxazoles capably engage many cysteines in the human proteome and the selectivity landscape of cysteines liganded by 3-bromo-4,5-dihydroxazoles is distinct from that of traditional haloacetamide electrophiles. We validated that 3-bromo-4,5-dihydroxazoles form covalent conjugation with glutathione S-transferase Pi (GSTP1) and peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1). A compound that targets multiple functionally important cysteines suppresses T cell activation and cytokine secretion without compromising cellular viability. Coupled with functional screening, this approach provides compound-target interactions that can modulate immune responses and their associated disorders.
View original record on NIH RePORTER →